275 related articles for article (PubMed ID: 17543791)
21. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
[TBL] [Abstract][Full Text] [Related]
22. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
Li X; Ishida H; Yamaguchi Y; Tanabe K
Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
[TBL] [Abstract][Full Text] [Related]
23. Successful lung transplantation in the presence of pre-existing donor-specific cytotoxic HLA Class II antibodies.
Lambeck AJ; Verschuuren EA; Bouwman I; Jongsma T; Roozendaal C; Bungener LB; van der Bij W; van den Berg AP; Erasmus ME; Timens W; Lems SP; Hepkema BG
J Heart Lung Transplant; 2012 Dec; 31(12):1301-6. PubMed ID: 23079068
[TBL] [Abstract][Full Text] [Related]
24. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
25. Alloantibodies in heart transplantation.
Ho EK; Vlad G; Colovai AI; Vasilescu ER; Schwartz J; Sondermeijer H; Burke E; Marboe CC; Itescu S; Suciu-Foca N; Mancini D
Hum Immunol; 2009 Oct; 70(10):825-9. PubMed ID: 19555730
[TBL] [Abstract][Full Text] [Related]
26. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction.
Muro M; Llorente S; Gónzalez-Soriano MJ; Minguela A; Gimeno L; Alvarez-López MR
Clin Transpl; 2006; ():379-83. PubMed ID: 18365392
[TBL] [Abstract][Full Text] [Related]
27. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
28. De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection.
Spriewald BM; Hugo C
Clin Transpl; 2006; ():469-72. PubMed ID: 18365405
[TBL] [Abstract][Full Text] [Related]
29. Flow Cytometry Panel-Reactive Antibody Screening of Anti-HLA Antibodies in the Waiting List Significantly Reduces the Occurrence of Acute Rejection After Kidney Transplantation.
Dedinská I; Mäčková N; Macháleková K; Miklušica J; Palkoci B; Fialová J; Čellár M; Galajda P; Mokáň M
Transplant Proc; 2017 Oct; 49(8):1719-1723. PubMed ID: 28923614
[TBL] [Abstract][Full Text] [Related]
30. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592
[TBL] [Abstract][Full Text] [Related]
31. [Anti-HLA antibody detection and rejection in kidney transplantation: impact of the new technologies].
Georgescu D; Ferrari-Lacraz S; Villard J
Rev Med Suisse; 2007 Apr; 3(108):1064-9. PubMed ID: 17552259
[TBL] [Abstract][Full Text] [Related]
32. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens.
Appel JZ; Hartwig MG; Davis RD; Reinsmoen NL
Hum Immunol; 2005 Apr; 66(4):378-86. PubMed ID: 15866701
[TBL] [Abstract][Full Text] [Related]
33. Anti-human leukocyte antigen antibodies, vascular C4d deposition and increased soluble c4d in broncho-alveolar lavage of lung allografts.
Girnita AL; Lee TM; McCurry KR; Baldwin WM; Yousem SA; Detrick B; Pilewski J; Toyoda Y; Jelinek L; Lomago J; Zaldonis D; Spichty KJ; Zeevi A
Transplantation; 2008 Jul; 86(2):342-7. PubMed ID: 18645500
[TBL] [Abstract][Full Text] [Related]
34. Histocompatibility testing for highly sensitized transplant candidates.
Saidman SL
Transplant Proc; 2007 Apr; 39(3):673-5. PubMed ID: 17445570
[TBL] [Abstract][Full Text] [Related]
35. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices.
Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ
Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717
[TBL] [Abstract][Full Text] [Related]
36. Subclinical peritubular capillaritis in serial graft biopsies in cadaveric kidney transplant recipient with pre-transplant anti-HLA antibodies.
Masutani K; Kitada H; Noguchi H; Tsuruya K; Katafuchi R; Tanaka M; Iida M
Clin Transplant; 2009 Aug; 23 Suppl 20():34-8. PubMed ID: 19594594
[TBL] [Abstract][Full Text] [Related]
37. [Effects of the HLA antibodies on allograft acute rejection after cadaveric liver transplantation].
Chen W; Chen GH; Lu MQ; Yang Y; Cai CJ; Hou BH; Lin Y; Zhang WD; Xiao LL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):774-6. PubMed ID: 16793598
[TBL] [Abstract][Full Text] [Related]
38. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
[TBL] [Abstract][Full Text] [Related]
39. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
[TBL] [Abstract][Full Text] [Related]
40. [Histocompatibility tests in a transplantation program].
de-Leo-Cervantes C
Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
